A Clinical Trial of Ginseng in Diabetes

Early Phase 1

Completed

• Conditions: Diabetes
• Interventions: Dietary Supplement: Placebo (sugar pill); Drug: Ginseng; Drug: ginsenoside RE

• Registration Number: NCT00781534
• Lead Sponsor: Washington University School of Medicine

Brief Summary

a clinical study of Ginseng its potential affect on diabetes

Detailed Description

Comparing three groups (those with \& without normal blood sugar levels) to see if there is any clinically significant change in blood sugar levels in relationship to those taking:

1. ginseng

2. ginsenoside RE (a type of metabolized ginseng)

3. placebo

Study Timeline

• Study Start: 2003-09
• Primary Completion: 2004-12
• Study Completion: 2008-09
• Study First Submitted: 2008-10-27
• Study First Submitted QC: 2008-10-27
• Study First Posted: 2008-10-29
• Status Verified: 2019-09
• Last Update Submitted: 2019-09-05
• Last Update Posted: 2019-09-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 19

Inclusion Criteria

• ages 18-65
• healthy, non-diabetic
• healthy, impaired glucose tolerance/mild diabetes (no medications required)

Exclusion Criteria

• impaired glucose tolerance (borderline diabetes that requires medications)
• diabetes (requiring medications)
• caffeine sensitivity
• known cardiac, peripheral vascular diseases
• arrhythmias (irregular heart rhythms)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
3. Placebo	Placebo (sugar pill)	placebo ("sugar" pill) group
2. Ginsenosdie RE	ginsenoside RE	Ginsenoside RE (a metabolite of ginseng) group
1. Ginseng	Ginseng	Ginseng group
2. Ginsenosdie RE	Ginseng	Ginsenoside RE (a metabolite of ginseng) group

Trial Locations

Locations (1)

Washington University School of Medicine; 🇺🇸 Saint Louis, Missouri, United States